Singapore: Ministry of Health provides clarifications on the provision of telemedicine services

In brief

The Ministry of Health (MOH) has provided further clarifications on the provision of telemedicine services. These clarifications relate to the importance of exercising governance, the duration of teleconsultations being commensurate with patients' needs, and the regulation of the implementation of artificial intelligence (AI) tools.


Contents

In more detail

In 2024, the MOH revoked a telemedicine service provider's license for clinically and ethically inappropriate practices. Further details may be found in our September 2024 and October 2024 client alerts.

In April 2025 the management of this telemedicine service provider announced that it would be implementing new safeguards. Among others, the new safeguards reportedly include a requirement for all teleconsultations it provides to be at least one minute long before issuing a medical certificate (MC).

Following this announcement, the MOH has provided clarifications on the provision of telemedicine services in Singapore, as follows:

  1. Licenses must exercise governance over the provision of medical services

The MOH emphasized that the ultimate responsibility for compliance with regulatory requirements lies with the licensee and its key officeholders. This includes day-to-day management of operations and the provision of clinical governance and technical oversight of clinical services. All healthcare professionals operating under the same license are under the supervision and oversight of the license holder, regardless of the corporate structure that governs their relationship.

  1. The duration of teleconsultations must be commensurate with patients' needs

The MOH reiterated that a teleconsultation that exceeds a minute does not necessarily mean that the telemedicine service meets the requisite standards. The quality and adequacy of medical care provided will vary based on patients' needs, and it is ultimately decided by whether the care provided is commensurate to the patients' needs.

  1. The implementation of AI tools is regulated

In response to the telemedicine company's plans to use AI tools on its teleconsultations platform to enhance clinical standards, transcribe doctor-patient conversations, and consolidate prescribed treatment plans and other relevant medical records, the MOH noted that while the use of AI could be beneficial, caution must be exercised to ensure that the use of AI is compliant with all necessary regulatory requirements. Inherent risks within the use of AI tools such as data bias, cybersecurity and confidentiality must also be robustly managed by licensees.

Key takeaways

The MOH was particularly active in its enforcement in the telemedicine industry in 2024. The breach of applicable license conditions when providing telemedicine services in Singapore involves a fine of up to SGD 20,000 and/or imprisonment for up to 12 months.

With the MOH's continued focus on regulatory requirements, data and digital health issues in the telemedicine and healthcare sectors, companies should pay close attention to their provision of licensed healthcare services and the implementation of AI tools.

* * * * *

LOGO_Wong&Leow_Singapore

© 2025 Baker & McKenzie. Wong & Leow. All rights reserved. Baker & McKenzie. Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

Copyright © 2025 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.